Biohaven Pharmaceutical Holding Company Ltd.
Equities
BHVN
VGG111961055
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
38.96 USD | +0.62% | +3.97% | -74.19% |
05-15 | Biohaven Insider Bought Shares Worth $512,877, According to a Recent SEC Filing | MT |
05-14 | Biohaven Insider Bought Shares Worth $1,002,470, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-74.19% | 541M | |
+59.89% | 55.07B | |
-1.93% | 41.79B | |
+44.36% | 40.22B | |
-8.29% | 28.17B | |
+12.25% | 26.28B | |
-21.02% | 18.93B | |
+6.79% | 13.03B | |
+28.44% | 12.26B | |
+25.92% | 12.21B |
- Stock Market
- Equities
- BHVN Stock
- News Biohaven Pharmaceutical Holding Company Ltd.
- Piper Sandler Initiates Biohaven at Overweight with $23 Price Target